HIV study: which drug combo shrinks the virus reservoir best?
NCT ID NCT02987530
First seen Apr 15, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tested two different once-daily HIV drug combinations in 101 people recently infected with HIV. The goal was to see which combo better reduces the amount of HIV DNA hiding in immune cells after 48 weeks. While both treatments control the virus, the study focuses on shrinking the hidden viral reservoir, not curing HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Bicetre
All the Regions of the Country (40 Centers), France
Conditions
Explore the condition pages connected to this study.